NCT02205320
|
2014-02-01 |
A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers
|
Phase 1
|
Recruiting
|
NCT01980940
|
2013-12-01 |
The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)
|
Phase 1/Phase 2
|
Completed
|
NCT01450098
|
2011-10-01 |
A Study of LY2484595 in Healthy Subjects
|
Phase 1
|
Completed
|
NCT00369928
|
2006-08-01 |
Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
|
Phase 2
|
Completed
|
NCT00801814
|
2006-04-01 |
Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia
|
Phase 2/Phase 3
|
Completed
|
NCT00791817
|
2005-08-01 |
Study to Evaluate Potential Food Effects
|
Phase 1
|
Completed
|
NCT00791388
|
2005-08-01 |
Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days
|
Phase 1
|
Completed
|
NCT00705653
|
2005-03-01 |
Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors
|
Phase 1
|
Completed
|
NCT00067236
|
2003-09-01 |
Study of Oral PG-116800 Following a Heart Attack
|
Phase 2
|
Completed
|
NCT00041756
|
2002-07-01 |
Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis
|
Phase 2
|
Completed
|